H4ZE:F:F-HSBC MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 18.81

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-6.54 (-1.18%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.81%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.46 (-0.80%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.11 (-0.72%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

-1.62 (-1.63%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.00 (-0.85%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.24%)

USD 41.48B
0ZC:F Zscaler Inc

-3.56 (-1.91%)

USD 37.92B
BSND:F Danone SA

-0.30 (-2.13%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.40 (-0.32%)

USD 24.77B

ETFs Containing H4ZE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.69% 80% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.69% 80% B- 72% C
Trailing 12 Months  
Capital Gain 9.06% 63% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.06% 60% D- 53% F
Trailing 5 Years  
Capital Gain 89.46% 58% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.46% 58% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 9.94% 67% D+ 64% D
Dividend Return 9.94% 64% D 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.15% 57% F 86% B+
Risk Adjusted Return 81.86% 80% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike